Crossmark

Mapping the medical outcomes study HIV health survey (MOS-HIV) to the EuroQoL 5 Dimension (EQ-5D-3 L) utility index

Crossref DOI link: https://doi.org/10.1186/s12955-019-1135-8

Published Online: 2019-05-10

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Shi, Yuan

Thompson, Jennifer

Walker, A. Sarah

Paton, Nicholas I.

Cheung, Yin Bun https://orcid.org/0000-0003-0517-7625
Funding

Funding for this research was provided by:

European and Developing Countries Clinical Trials Partnership (IP.2007.33011.003)

Instituto de Salud Carlos III (A107/90015)
License Information

Text and Data Mining valid from 2019-05-10
More Information

Article History

Received: 18 January 2019

Accepted: 1 April 2019

First Online: 10 May 2019

Ethics approval and consent to participate

: This secondary analysis was approved by the National University of Singapore Institutional Review Board (S-17-017E). The trial protocol was approved by ethics committees in all participating countries and by the research ethics committee of the University College London, UK.Informed consent was obtained from all individual participants or their caregivers, in the case of participants less than 18 years of age, included in the study. Patients below 18 years of age also gave assent.

: Not applicable.

: All authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.